Objective: To discuss the value of general movements assessment in predicting the neurological disorders. Methods: Using PubMed as the search engine, we searched to identify relevant studies in English and Chinese language published up to November 2014 and 19 studies were selected. Standard methods in meta-analyses were used to provide diagnostic accuracy by Meta-DiSc 1.4. Results: For non–cerebral palsy (non-CP) as outcome for writhing period, the results suggested a good sensitivity and a specificity of 0.74, the Q-value was 0.80. The area under the curve (AUC) was 0.87. For non-CP as outcome for fidgety period, the results suggested both high level for sensitivity and specificity. And the Q-value was 0.914, the AUC was 0.9664. For CP as outcome for writhing and fidgety periods, good sensitivity and specificity were found in the analysis, and the Q-value was 0.9034 while the AUC was 0.9592. Conclusion: General movements assessment is a good predictor for diagnosing neurological disorders.
AddeLRyggMLossiusKObergGKStoenR. General movement assessment: predicting cerebral palsy in clinical practise. Early Hum Dev. 2007;83:13-18.
2.
BrognaCRomeoDMCervesiC. Prognostic value of the qualitative assessments of general movements in late-preterm infants. Early Hum Dev. 2013;89:1063-1066.
3.
Management of malignant pleural effusions. Am J Respir Crit Care Med. 2000;162:1987-2001.
4.
HamerEGBosAFHadders-AlgraM. Assessment of specific characteristics of abnormal general movements: does it enhance the prediction of cerebral palsy?Dev Med Child Neurol. 2011;53:751-756.
5.
BurgerMFriegALouwQA. General movements as a predictive tool of the neurological outcome in very low and extremely low birth weight infants—a South African perspective. Early Hum Dev. 2011;87:303-308.
6.
YugeMMarschikPBNakajimaY. Movements and postures of infants aged 3 to 5 months: to what extent is their optimality related to perinatal events and to the neurological outcome?Early Hum Dev. 2011;87:231-237.
7.
GroenSEde BlecourtACPostemaKHadders-AlgraM. General movements in early infancy predict neuromotor development at 9 to 12 years of age. Dev Med Child Neurol. 2005;47:731-738.
8.
Seme-CigleneckiP. Predictive values of cranial ultrasound and assessment of general movements for neurological development of preterm infants in the Maribor region of Slovenia. Wien Klin Wochenschr. 2007;119:490-496.
9.
ButlerCChambersHGoldsteinM. Evaluating research in developmental disabilities: a conceptual framework for reviewing treatment outcomes. Dev Med Child Neurol. 1999;41:55-59.
10.
Hadders-AlgraMGroothuisAM. Quality of general movements in infancy is related to neurological dysfunction, ADHD, and aggressive behaviour. Dev Med Child Neurol. 1999;41:381-391.
11.
ShiMJWenXHHuangJH. Study on the predictive validity of quality evaluation of general movements for neurological development outcome of high risk infants. Matern Child Health Care China. 2011;26:3.
12.
YangHShiWShaoXM. Study of predictive validity and reliablility of qualitative general movements assessment for neurological outcome in high risk neonates. Chin J Evid Based Pediatr. 2007;2:172-180.
13.
SuYPYangHShiW. Predictive value of qualititive assessment of general movements for motor developmental outcome (cerebral palsy) in full-term infants with cerebral damage. Chin J Child Health Care. 2014;22:680-682, 695.
14.
BaoKXWangYQYangZX. Value contrast of GMS and neurological assessment in early central nervous system development of children in department of rehabilitation. Chin Med Guides. 2014;11:151-153.
15.
NakajimaYEinspielerCMarschikPBBosAFPrechtlHF. Does a detailed assessment of poor repertoire general movements help to identify those infants who will develop normally?Early Hum Dev. 2006;82:53-59.
16.
PrechtlHFEinspielerCCioniGBosAFFerrariFSontheimerD. An early marker for neurological deficits after perinatal brain lesions. Lancet. 1997;349:1361-1363.
17.
HabelLACapraAMOestreicherN. Mammographic density in a multiethnic cohort. Menopause. 2007;14:891-899.
18.
CohenJFChalumeauMCohenRKorevaarDAKhoshnoodBBossuytPM. Cochran’s Q test was useful to assess heterogeneity in likelihood ratios in studies of diagnostic accuracy. J Clin Epidemiol. 2015;68:299-306.
19.
BabbsCF. Choosing inclusion criteria that minimize the time and cost of clinical trials. World J Methodol. 2014;4:109-122.
20.
GieradaDSPinskyPNathHChilesCDuanFAberleDR. Projected outcomes using different nodule sizes to define a positive CT lung cancer screening examination. J Natl Cancer Inst. 2014;106(11). doi:10.1093/jnci/dju284.
